4 Item 1A. Risk Factors Item 1B. Unresolved Staff Comments 74 Item 1C. Cybersecurity 75 Item 2. Properties 75 Item 3. Legal Proceedings 75 Item 4. Mine Safety Disclosures 76 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 77 Item 6. [Reserved] 78 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 79 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 90 Item 8. Fi...
Q2 FY2026 — expected 2026-08-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-076739 | EDGAR | 102K words |
| 2025-02-26 | 2024-12-31 | 0000950170-25-027756 | EDGAR | — |
| 2024-02-22 | 2023-12-31 | 0000950170-24-018797 | EDGAR | — |
| 2023-02-23 | 2022-12-31 | 0000950170-23-004123 | EDGAR | — |
| 2022-02-24 | 2021-12-31 | 0000950170-22-001978 | EDGAR | — |
| 2021-03-25 | 2020-12-31 | 0001564590-21-015518 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001193125-25-269601 | EDGAR | 63K words |
| 2025-08-07 | 2025-06-30 | 0000950170-25-105054 | EDGAR | — |
| 2025-05-05 | 2025-03-31 | 0000950170-25-063553 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0000950170-24-122332 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0000950170-24-091837 | EDGAR | — |
| 2024-05-02 | 2024-03-31 | 0000950170-24-052135 | EDGAR | — |
| 2023-11-02 | 2023-09-30 | 0000950170-23-058237 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0000950170-23-039874 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0000950170-23-017894 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0000950170-22-021892 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0000950170-22-014809 | EDGAR | — |
| 2022-05-05 | 2022-03-31 | 0000950170-22-007873 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-16 | 0001193125-26-107312 | EDGAR | 2K words |
| 2026-03-11 | 0001193125-26-102178 | EDGAR | — |
| 2026-02-26 | 0001193125-26-076617 | EDGAR | — |
| 2026-02-03 | 0001193125-26-034422 | EDGAR | — |
| 2025-11-06 | 0001193125-25-269536 | EDGAR | — |
| 2025-08-07 | 0000950170-25-105022 | EDGAR | — |
| 2025-06-11 | 0001193125-25-139146 | EDGAR | — |
| 2025-06-06 | 0001193125-25-137162 | EDGAR | — |
| 2025-06-04 | 0001193125-25-134908 | EDGAR | — |
| 2025-05-05 | 0000950170-25-063539 | EDGAR | — |
97 total filings indexed. 69 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001812364 |
| Ticker | RLAY |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.relaytx.com |
| Listed | 2020-07-16 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report